Tag: European

Global Heart Organizations Unite to Promote Clinician Well-Being

Global action is needed to improve clinician well-being and reduce burnout, both of which are and will be crucial for providing high-quality patient care, four...

Short-Acting Beta Agonist Overuse ‘a Global Public Health Issue’

About one third of asthma patients have high use of short-acting beta agonists (SABAs) in Europe across all severity levels, said Santiago Quirce, MD, PhD,...

Mental Health Woes Prevalent in Women With Urinary Incontinence

Women with urinary incontinence are significantly more likely to have mental health problems than women without incontinence, results of a large survey suggest. In a...

SLE Neuropsych Event Etiology Helps Define Predictors, Outcomes

Different kinds of neuropsychiatric (NP) events in patients with systemic lupus erythematosus (SLE) have substantial variability in their occurrence, resolution, and recurrence over time, as...

IV Iron Can Save Costs in HF With Iron Deficiency in Analysis

Intravenous iron therapy was predicted to be highly cost-effective or even cost-saving when used in high-risk, iron-deficient patients with heart failure (HF) in each of...

Positive Top-Line Results for Empagliflozin in HFpEF

Treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance, Boehringer Ingelheim/Eli Lilly) significantly reduces the risk of cardiovascular death or hospitalization for heart failure...

Iron-Clad Benefits of CRT Seen in Reduced-EF Heart Failure

The case for the use of intravenous iron therapy for some patients with heart failure (HF) and reduced ejection fraction (HFrEF) has strengthened in recent...

Novel Liver Dialysis Device May Safely Curb ACLF

An investigational liver dialysis device (DIALIVE) was associated with significantly greater survival of patients with acute-on-chronic liver failure (ACLF), compared with the standard of care...

EC Approves Cemiplimab for Advanced or Metastatic BCC

The European Commission (EC) has approved cemiplimab (Libtayo) for the treatment of adults with locally advanced or metastatic basal cell carcinoma (BCC) who progressed on —...

Noted Ability of Mozart’s Music to Reduce Seizures Explained?

Listening to Mozart has a notable impact on seizure reduction in patients with epilepsy —  and now researchers believe they know why, new research suggests....

Reduced-Intensity Transplant Benefits Older Patients With AML

Among older patients with acute myeloid leukemia (AML), survival is significantly better when they undergo reduced-intensity condition (RIC) before receiving an allogeneic hematopoietic cell transplant...

Zanubrutinib Better Than Ibrutinib in CLL/SLL?

Zanubrutinib (Brukinsa), a second-generation Bruton tyrosine kinase (BTK) inhibitor, has shown a significantly greater delay in disease progression vs the standard of care ibrutinib (Imbruvica)...

Luspatercept Benefit Also in Non-Transfusion-Dependent Thalassemia

The first-in-class erythroid maturation agent luspatercept (Reblozyl) is already approved for the treatment of anemia in adult patients with beta thalassemia who require red blood...

EMA Seeks More Data on Myocarditis After COVID-19 Shots

The European Medicines Agency (EMA) safety committee is continuing its review of myocarditis and pericarditis following vaccination with COVID-19 vaccines. “Currently, further analysis is needed...

Immunotherapy Combo Now Approved for First-Line Mesothelioma in EU

Combination therapy with the immunotherapies nivolumab (Opdivo) and ipilimumab (Yervoy) is now approved in the European Union for the first-line treatment of adults with unresectable...

Virtual EULAR Congress Aims for Patient-Inclusive Programming

Although clinicians and researchers dominate attendance at medical conferences, patients have always been welcome at many such meetings. The movement of most conferences to an...

Being Firstborn Linked to Lower Heart Disease Risk

May 26, 2021 — Birth order and number of siblings may be tied to a person’s risk for heart disease and mortality, according to a study covering...

PASCAL Mitral Valve Repair Shines at 2 Years in CLASP

Transcatheter mitral valve repair with the PASCAL device showed high rates of survival and freedom from heart failure rehospitalization at 2 years in the single-arm,...

‘Calcium Imbalance’ Linked to Bipolar Severity

Calcium homeostasis may play a role in bipolar disorder (BD) severity, with raised serum vitamin D and parathyroid hormone (PTH) levels linked to worse clinical...

European Union to Allow Vaccinated US Tourists This Summer

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. US tourists who have been fully vaccinated against COVID-19 will be...

EU Panel Likes Azacitidine for AML Maintenance

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion of azacitidine (Onureg) for use as maintenance therapy...

Tralokinumab Gets Nod for Atopic Dermatitis in Europe

On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for the IL-13 inhibitor...

Widen Use of General Anesthesia in End-of-Life Care, Say Experts

General anesthesia should be an option for patients at the end of life as a means of easing the physical and mental distress that can...

Worldwide COVID-19 Cases Reached New Weekly Record

More COVID-19 cases were reported worldwide last week than in any other seven-day period during the pandemic, according to new data published Tuesday by the...

Serious, ‘Unexpected’ Adverse Events From Nasal Esketamine

Patients who receive esketamine for treatment-resistant depression (TRD) are at increased risk for serious and unexpected adverse events (AEs), new research suggests. Results showed that...